Renal Replacement Anticoagulant Management (RRAM)
The Renal Replacement Anticoagulant Management (RRAM) study will research the advantages and disadvantages of the two anticoagulant methods for patients with a kidney injury and treated in an ICU
Part of our ongoing collaboration with the Intensive Care National Audit and Research Centre (ICNARC), the National Institute for Health and Care Research (NIHR)-funded (16/111/136) Renal Replacement Anticoagulation Management showcases our ability to link and process large volumes of routine health data to inform patient management. The study investigated a change in practice in blood thinning to allow kidney replacement therapy in the critically ill, finding no evidence of benefit but significantly increased healthcare costs. The findings were highlighted in the NIHR publication “7 findings that could save the NHS money and improve care” and led to an NIHR alert.
For more information about the RRAM study, please visit the ICNARC website.